In an earlier study, the application of Luteolin at 40 mg/kg caused effective inhibition of tumor growth in BGC-823 gastric carcinoma xenografts in mice, and the mechanism of inhibition of tumor growth was suggested to be related to the stimulation of immune response and suppression of VEGF-A and MMP-9 expressions [87]. The gene discussed is VEGFA; the disease is neoplasm.